Mean Platelet Volume/Lymphocyte Ratio as a Prognostic Indicator for HBV-Related Decompensated Cirrhosis

Table 1

Clinical characteristics of studied subjects.

	Total patients ()
Gender (male/female)	83/18
Age (years)
Total protein (g/L)
Albumin (g/L)
ALT (U/L)	32.0 (18.0–49.5)
AST (U/L)	49.0 (31.5–73.5)
Serum creatinine (μmol/L)	74.0 (61.0–89.0)
Total bilirubin (μmol/L)	50.0 (22.5–131.0)
INR
MPV (fl)	16.0 (13.6–18.9)
Lymphocyte count (×10^9/L)	1.00 (0.65–1.40)
MPVLR	15.1 (9.9–25.7)
PLTs (×10^9/L)	76.0 (38.0–123.0)
MELD score	13.5 (8.6–17.8)
CP score	9.0 (8.0–11.0)
Modes of decompensation
HE, (%)	1 (1.0%)
HRS, (%)	10 (10.0%)
Ascites, (%)	69 (68.3%)
Variceal bleeding, (%)	25 (24.8%)
3-month mortality, (%)	38 (37.6%)

Data are expressed as , , or median (interquartile range). Abbreviations: ALT: alanine aminotransferase; AST: aspartate aminotransferase; INR: international normalized ratio; MPV: mean platelet volume; MPVLR: mean platelet volume/lymphocyte ratio; PLTs: platelet counts; MELD score: model for end-stage liver disease score; CP score: Child-Pugh score; HE: hepatic encephalopathy; HRS: hepatorenal syndrome; HBV-DC: HBV-related-decompensated cirrhosis.